KRAS and colorectal carcinoma: However, not all sporadic CRCs harbor defects in APC, KRAS and/or TP53, and thus, additional genes are proposed to contribute to CRC pathogenesis, particularly those that impact genome stability and will adversely impact large cohorts of genes that may be critical for CRC pathogenesis [37,38,39,40].